Results 231 to 240 of about 738,044 (342)

Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma

open access: yesModern Pathology, 2019
Vignesh Shanmugam   +5 more
semanticscholar   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

Ewing's sarcoma of the calcaneus bone [PDF]

open access: diamond, 2015
Atul Tiwari   +2 more
openalex   +1 more source

Linking the NETSARC+ National Sarcoma Database With the SNDS to Evaluate Adjuvant and/or Neoadjuvant Therapy: Report on the Linkage Process and Result (Health Data Hub's DEEPSARC Pilot Project). [PDF]

open access: yesFundam Clin Pharmacol
Drezen E   +12 more
europepmc   +1 more source

An aggressive soft-tissue sarcoma of the extremity: A myxofibrosarcoma, grade 3 (FNCLCC system)

open access: gold
Manuela Montatore   +6 more
openalex   +1 more source

Improved survival using specialized multidisciplinary board in sarcoma patients

open access: yesAnnals of Oncology, 2017
Jean-Yves Blay   +29 more
semanticscholar   +1 more source

Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Purpose Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy with limited therapeutic options in the recurrent/metastatic setting; little is known regarding its responsiveness to immunotherapy. Inhibition of enhancer of zeste homolog 2 (EZH2) has been shown to improve T‐cell‐mediated killing and susceptibility to immune checkpoint ...
Elisabetta Xue   +12 more
wiley   +1 more source

DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma

open access: yesNature Medicine, 2017
Nathan C. Sheffield   +37 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy